Skip to main content

Table 2 PFS and OS rates at 5, 10, 15, 20 years between patients treated with RT + CT and RT alone

From: Adjuvant chemotherapy in average-risk adult medulloblastoma patients improves survival: a long term study

 

RT+CT

RT

PFS-5

86.9% ± 7.1%

87.3% ± 6.9%

PFS-10

82.3% ± 8.0%

46.2% ± 13.1%

PFS-15

82.3% ± 8.0%

38.5% ± 13.0%

PFS-20

82.3% ± 8.0%

38.5% ± 13.0%

OS-5

95.2% ± 4.6%

95.7% ± 4.3%

OS-10

89.3% ± 7.2%

74.1% ± 10.3%

OS-15

89.3% ± 7.2%

52.0% ± 13.1%

OS-20

89.3% ± 7.2%

41.6% ± 14.0%